Altimmune Inc (ALT)
6.74
0.00 (0.00%)
USD |
NASDAQ |
Nov 01, 16:00
6.70
-0.04
(-0.59%)
After-Hours: 20:00
Altimmune Total Assets (Quarterly): 173.35M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 173.35M |
March 31, 2024 | 188.36M |
December 31, 2023 | 210.64M |
September 30, 2023 | 166.57M |
June 30, 2023 | 183.32M |
March 31, 2023 | 187.08M |
December 31, 2022 | 206.93M |
September 30, 2022 | 225.28M |
June 30, 2022 | 209.91M |
March 31, 2022 | 205.66M |
December 31, 2021 | 218.86M |
September 30, 2021 | 236.91M |
June 30, 2021 | 257.26M |
March 31, 2021 | 264.25M |
December 31, 2020 | 245.12M |
September 30, 2020 | 233.00M |
June 30, 2020 | 102.54M |
March 31, 2020 | 54.23M |
December 31, 2019 | 54.06M |
September 30, 2019 | 56.39M |
June 30, 2019 | 61.98M |
March 31, 2019 | 65.37M |
December 31, 2018 | 54.75M |
September 30, 2018 | 52.86M |
June 30, 2018 | 52.10M |
Date | Value |
---|---|
March 31, 2018 | 60.87M |
December 31, 2017 | 63.03M |
September 30, 2017 | 74.35M |
June 30, 2017 | 90.84M |
March 31, 2017 | 20.73M |
December 31, 2016 | 38.40M |
September 30, 2016 | 140.54M |
June 30, 2016 | 27.93M |
March 31, 2016 | 18.73M |
December 31, 2015 | 19.86M |
September 30, 2015 | 20.90M |
June 30, 2015 | 22.62M |
March 31, 2015 | 25.47M |
December 31, 2014 | 21.98M |
September 30, 2014 | 23.35M |
June 30, 2014 | 15.22M |
March 31, 2014 | 14.37M |
December 31, 2013 | 17.14M |
September 30, 2013 | 20.62M |
June 30, 2013 | 24.59M |
March 31, 2013 | 21.97M |
December 31, 2012 | 22.74M |
September 30, 2012 | 23.41M |
June 30, 2012 | 23.81M |
March 31, 2012 | 24.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
54.06M
Minimum
Dec 2019
264.25M
Maximum
Mar 2021
190.70M
Average
206.93M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 75.61B |
Viking Therapeutics Inc | 937.89M |
Amgen Inc | 90.88B |
Avid Bioservices Inc | 334.64M |
NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 20.82M |
Shareholders Equity (Quarterly) | 152.53M |
Current Ratio | 11.30 |